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Hepatitis B virus is a blood borne and sexually transmitted pathogen 
that is spread through percutaneous and mucosal exposure to infected 
blood and body fluids. Major modes of acquiring the infection included 
intravenous drug use, sexual intercourse with infected partners, and 
perinatal transmission from mother to child among others. The virus 
has caused severe epidemic in parts of Africa and Asia (Ryan & Ray, 
2004) and approximately 350 million persons worldwide are infected 
with the virus (Ferriara,2000; Droston et al., 2004; Cheesbrough, 
2006), resulting in 2 million deaths annually.  
 
Nigeria is classified among the countries highly endemic for viral 
hepatitis (Sirisena, 2000). The prevalence of HBsAg in normal 
population in Nigeria ranges from 2.7 to 13.3 % ( Kulkarimi et al., 
1986; Muula, 2000). Like in the case of HIV, the highest incidence of 
the acute infection is among the young adults of 20-30years. HBV spot 
surveys amongst pregnant women in the country revealed 4.3% 
prevalence in Port Harcourt (Akani et al., 2005), 15.1% in Jos (Egah et 
al., 2007) and 8.3% in Zaria (Luka et al., 2008). Generally, pregnant 
women have depressed immunity, thus infection of HBV is of clinical 
importance. Oguntola (2008) observed that hepatitis is one of the 
diseases in pregnancy that causes jaundice in women and if left 
untreated may lead to babies with low intelligent quotient. A hepatitis B 
positive pregnant mother also confers a 20% risk of passing the 
infection to her offspring. Siriprakash & Anil (1997) reported that 
neonates who contact HB infection will almost have 90% risk of 
developing chronic hepatitis and chronic liver disease. 
 
The aim of this investigation is to study the epidemiology of HBV 
infection among pregnant women attending ante natal clinic at General 
hospital Minna, Nigeria State, Nigeria. This will generate information 
that could be used to monitor the trend of the disease in the area. It is 
recommended that HBV should be incorporated into the screening 





A descriptive cross sectional study was conducted amongst 261 pregnant women attending ante natal clinic at General hospital, 
Minna, Nigeria to determine the social characteristics and seroprevalence of Hepatitis B Virus (HBV). The mean age  of the 
respondents was 25years. Thirty two (12.3%) of the 261 blood samples tested positive for HBV. Of the the +ve cases, 13.6% were 
in the second trimester of their pregnancy and 60% within the age brackets of 21-30 years. Illiterate women constituted 15.9% of 
those sampled while civil servants were 13.6%. Testing for HBsAg is recommended for all pregnant women at first prenatal visit so 
that positive mothers receive prompt intervention. 
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MATERIALS AND METHODS 
Study area 
The study was carried out at the General Hospital in Minna, Niger 
State, Nigeria. Minna located on latitude 9o37’N and longitude 6o33’E. 
The climate of Minna is within a region described as tropical climate 
which is characterised by tropical dry and wet seasons. The region is 
characterized by double rainfall maxima in the months of April and 
August. The rainy season commences in April and lasts till October. 
Temperature is uniformly high throughout the year except from July to 
August when the clouding of the sky prevents direct isolation (Kowal & 
Knabe, 1972).   
 
Study design 
The study was a hospital based descriptive cross sectional survey 
conducted between 1st October and 30th November, 2007 at the 
antenatal clinic of the General Hospital, Minna, Niger State Nigeria. On 
every antenatal day, the pregnant women were given health talk on 
HIV/AIDS and hepatitis infections and were advised on the need to 
know their status. Only consenting attendees were recruited and 
included in the study. 
 
Administration of questionnaire/ interview 
Pre-structured questionnaires were administered to two hundred and 
sixty one (261) consenting pregnant women. Respondents who could 
not read or write were interviewed in Hausa language by the 
researcher assisted by nurses and matrons. Each questionnaire was 
designed to obtain demographic data such as age, occupation, 
educational status. Risk factor information were also obtained and 
these included stage of pregnancy, history of blood transfusion, and 
history of jaundice, whether or not respondents share sharp objects 
like razors and toothbrushes and types of marriage. 
 
Collection of blood samples/ serum preparation 
Blood samples were collected aseptically by venepuncture using 5 ml 
sterile disposable hypodermic syringes and needles on antenatal clinic 
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days-Mondays, Tuesdays and Thursdays and dispensed into pre-
labelled specimen bottles and transferred to the immunology 
laboratory of the hospital. The samples were allowed to clot and 
centrifuged at 3,000 rpm for 5mins to separate the serum. The sera 
were extracted using micropipette into 1.25 ml screw cap tubes and 
stored, at -20o C until required. 
 
Procedure for detecting HBsAg   
Hepatitis B surface antigen (HBsAg) detection was done using the in 
vitro diagnostic kit manufactured by Wondfo Biotech Co., Ltd, USA. 
The test kit (dipsticks) is a rapid immunochromatographic assay 
designed for qualitative determination of HBsAg in human serum or 
plasma. Assays were carried out at room temperature. The sera 
samples were removed from the freezer and left at room temperature 
to thaw. The test strips were removed from their foil pouches and 
immersed into serum samples with arrows pointing towards the 
samples. The strips were taken out after about 10secs and placed on 
a clean, dry, non-absorbent surface. This is to allow time for the 
reaction to take place. It was observed that the specimen was 
absorbed into the test strips and moved by capillary action upward 
towards the control line. Results were read after 10mins post 
immersion. Positive samples generated a colour band in the test 
region of the strips and another in the control region while negative 
samples had a colour band in the control regions only. 
 
Data Analysis 
Data from questionnaire were analyzed using SPSS version 15.0.  
Chi-square was used to compare significant differences between HBV 
prevalence, the odds ratio was used to determine association between 
infection and risk factors. Significance was determined at P < 0.05 at 
95% Confidence Interval. 
 
Informed consent 
Informed consent was obtained from the hospital management board 
through the Medical Director of the hospital and from the antenatal 
clinic attendees with assurance that all information obtained would be 
treated as confidential, and would be used for the purpose of this 
study only.   
 
RESULTS 
The results of the seroprevalence study are presented in Table 1. It 
showed that out of the 261 pregnant women tested, 32 were positive 
for HBsAg giving an overall seroprevalence of 12.3%. With respect to 
age, the results show that there is increase in HBsAg titres with 
increase in age up to 30 years followed by a decline. Statistically, 
however, there was no significant association (X2=3.19; P=0.784 ) 
between age and seroprevalence of Hepatitis B infection.  
 
TABLE 1. SEROPREVALENCE OF HEPATITIS B VIRUS  




No +ve (%) 
11-15 7 2 (6.3) 
15-20 70 7 (21.9) 
21-25 79 10 (31.3) 
26-30 71 10 (31.3) 
31-35 28 3 (9.4) 
36-40 5 0 (0.0) 
41-45 1 0 (0.0) 
 261 32(12.3) 
                              X2=3.196      df=6     p=0.784    
 
The level of educational attainment and occupation and 
seroprevalence of the pregnant women are presented in Table 2. It 
revealed that there is inverse relationship between educational 
attainment of the women and seroprevalence of Hepatitis infection. 
Details show that women with high prevalence of the infection are 
illiterates (15.90%) while those with some levels of education had 
lower prevalences even though there was no significant association 
(X2=1.981; P=0.576). Similarly, the result revealed that housewives 
had higher prevalence (13.60%) than the other women considered in 
the study. Despite this observation, no significant association 
(X2=1.145; P=0.766) between infection and the occupation of the 
women. There was no significant association (X2=1.429; P=0.651) 
between infection and pregnancy stages of the women (Table 3)..  
 










































Education X2= 1.981    df= 3    p= 0.576 
Occupation X2= 1.145    df= 3     p= 0.766 
 
TABLE 3. HBV SEROPOSITIVITY AND STAGE OF PREGNANCY 
 


















































Total 77 6 (7.8) 1.95 0.77 
 
DISCUSSION 
Viral hepatitis infection remains a public health problem in developing 
countries. The 12.3% overall prevalence for HBsAg in pregnant 
women attending antenatal clinic at General Hospital Minna falls within 
figures reported for other African countries. This also corroborates the 
World Health Organisation (WHO, 1990) report for Nigeria as highly 
endemic area with a prevalence  greater than 8%. In related studies in 
different parts of Nigeria, higher prevalence rates of 11.6% were 
reported  among pregnant women in Maiduguri (Harry et al., 1994), 
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Lower reports  included 2.19 % in Benin City (Onakewhor et al., 2008), 
4.3% in Port Harcourt in 2005 (Akani et al., 2005) and  2.89%  in 2006 
(Obi et al., 2006) and 5.7% in Ilorin (Agbede et al., 2007). Though within 
the same continent, the result of this study is higher than the 6.3% 
reported in pregnant women in Tanzania (Mendez, 1999) and 3.7% in 
Ethiopia (Awole & Gebre-Selassie, 2005).  
 
Similar studies in other parts of the world were 10% in Hong Kong 10% 
(Kong et al.,1997),  10% in India  (Sharma et al., 1995), 11% in Papua 
New Guinea  (Clegg, 1991), 12% in Taiwan (Lin et al., 2003), 14.3% and 
17.3% in Burkino Faso (Collenberg et al., 2003 or 2006?), agreeing with 
Juszozyk (2000) that the global prevalence of chronic HBV infection 
varies, highest in Africa, Asia and the Western pacific (>8%) to 
intermediate (2-7%) in Southern and Eastern Europe and lowest (< 2%) 
in Western Europe, North America and Australia.  
 
Age is an important factor in epidemiology studies. The age of acquiring 
infection was found to be the major determinant of the incidence of HBV 
(Zali et al., 1996).  
 
Analysis showed that out of the 261 respondents, (33.7%) were 
illiterates out of which 43.8% tested positive for HBsAg. There is inverse 
association between educational status and HBsAg positivity with less 
less educated women showing the highest positivity, indicating the 
positive influence of education and public enlightenment/awareness on 
the carrier rate of HBV infection. Although HB infection is considered 
one of the most important occupational infectious hazards in developed 
countries (Abdoo-Karim et al., 1989), results from this study did not 
reveal statistical significance between HB seropositivity and the different 
occupations of the pregnant women studied. 
 
Most of the studied women (157, 60.2%) were in the 2nd trimester of 
gestation. This group also had the highest HBsAg seropositivity 13.4% 
(21/157), followed by those in the 3rd trimester of gestation. Result from 
the study also revealed that those in the 3rd trimester were more likely to 
be infected (OR=1.947) than those in the 1st and 2nd trimesters. 
 
CONCLUSION 
Since the virus can be transmitted from infected mother to the offspring 
especially at birth, the presence of hepatitis B infection in women in 
general and pregnant women in particular calls for concern. There is 
need for screening of all pregnant women and infants born to hepatitis B 
positive mothers. Government and Non-governmental organisations 
should intensify efforts to enlighten the general population on the public 
health importance of the disease, and hepatitis screening should be 
incorporated into the routine antenatal screening. Further study to follow 
up cases of HBsAg positive pregnant women and effect of the positivity 
on their babies is also important.  
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